Genetic deficiency of tartrate-resistant acid phosphatase associated with skeletal dysplasia, cerebral calcifications and autoimmunity

[1]  L. Yam,et al.  Biology and Clinical Significance of Tartrate-Resistant Acid Phosphatases: New Perspectives on an Old Enzyme , 2009, Calcified Tissue International.

[2]  B. Zabel,et al.  Mutations in MMP9 and MMP13 determine the mode of inheritance and the clinical spectrum of metaphyseal anadysplasia. , 2009, American journal of human genetics.

[3]  L. Steinman.  A molecular trio in relapse and remission in multiple sclerosis , 2009, Nature Reviews Immunology.

[4]  M. Shinohara,et al.  Regulation of T-helper-cell lineage development by osteopontin: the inside story , 2009, Nature Reviews Immunology.

[5]  H. Weiner,et al.  Increased Osteopontin Expression in Dendritic Cells Amplifies IL-17 Production by CD4+ T Cells in Experimental Autoimmune Encephalomyelitis and in Multiple Sclerosis1 , 2008, The Journal of Immunology.

[6]  M. Jadot,et al.  Acid phosphatase 5 is responsible for removing the mannose 6-phosphate recognition marker from lysosomal proteins , 2008, Proceedings of the National Academy of Sciences.

[7]  M. Shinohara,et al.  Engagement of the type I interferon receptor on dendritic cells inhibits T helper 17 cell development: role of intracellular osteopontin. , 2008, Immunity.

[8]  A. Hayman.  Tartrate-resistant acid phosphatase (TRAP) and the osteoclast/immune cell dichotomy , 2008, Autoimmunity.

[9]  D. Denhardt,et al.  Control of osteopontin signaling and function by post‐translational phosphorylation and protein folding , 2007, Journal of cellular biochemistry.

[10]  T. Burdo,et al.  Osteopontin prevents monocyte recirculation and apoptosis , 2007, Journal of leukocyte biology.

[11]  C. Gohr,et al.  Osteopontin promotes pathologic mineralization in articular cartilage. , 2007, Matrix biology : journal of the International Society for Matrix Biology.

[12]  G. Mortier,et al.  qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data , 2007, Genome Biology.

[13]  C. Stokes,et al.  TRACP Influences Th1 Pathways by Affecting Dendritic Cell Function , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[14]  L. Glimcher,et al.  Osteopontin expression is essential for interferon-α production by plasmacytoid dendritic cells , 2006, Nature Immunology.

[15]  E. Boltshauser,et al.  Spondyloenchondrodysplasia with spasticity, cerebral calcifications, and immune dysregulation: Clinical and radiographic delineation of a pleiotropic disorder , 2006, American journal of medical genetics. Part A.

[16]  Anna Ingolfsdottir,et al.  Allegro version 2 , 2005, Nature Genetics.

[17]  N. Sträter,et al.  Crystal structures of recombinant human purple Acid phosphatase with and without an inhibitory conformation of the repression loop. , 2005, Journal of molecular biology.

[18]  T. Ahrens,et al.  Osteopontin functionally activates dendritic cells and induces their differentiation toward a Th1-polarizing phenotype. , 2005, Blood.

[19]  D. Hume,et al.  Macrophages overexpressing tartrate-resistant acid phosphatase show altered profile of free radical production and enhanced capacity of bacterial killing. , 2005, Biochemical and biophysical research communications.

[20]  C. Lam,et al.  Elevation of plasma osteopontin concentration is correlated with disease activity in patients with systemic lupus erythematosus. , 2005, Rheumatology.

[21]  R. Ravazzolo,et al.  Two single-nucleotide polymorphisms in the 5' and 3' ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus. , 2005, Arthritis and rheumatism.

[22]  M. Suga,et al.  Differentiation, Maturation, and Survival of Dendritic Cells by Osteopontin Regulation , 2005, Clinical Diagnostic Laboratory Immunology.

[23]  K. Hollberg,et al.  TRACP as an Osteopontin Phosphatase , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[24]  C. Polman,et al.  Elevated osteopontin levels in active relapsing‐remitting multiple sclerosis , 2003, Annals of neurology.

[25]  H. Cantor,et al.  Phosphorylation‐dependent interaction of osteopontin with its receptors regulates macrophage migration and activation , 2002, Journal of leukocyte biology.

[26]  G. Schneider,et al.  Phosphatase and oxygen radical-generating activities of mammalian purple acid phosphatase are functionally independent. , 2002, Biochemical and biophysical research communications.

[27]  Sheila J. Jones,et al.  Overlapping functions of lysosomal acid phosphatase (LAP) and tartrate-resistant acid phosphatase (Acp5) revealed by doubly deficient mice. , 2001, Development.

[28]  Jorge R. Oksenberg,et al.  The Influence of the Proinflammatory Cytokine, Osteopontin, on Autoimmune Demyelinating Disease , 2001, Science.

[29]  V. Parikka,et al.  Tartrate-resistant acid phosphatase facilitates hydroxyl radical formation and colocalizes with phagocytosed Staphylococcus aureus in alveolar macrophages. , 2001, Biochemical and biophysical research communications.

[30]  P. Lehner,et al.  Tartrate-resistant Acid Phosphatase (Acp 5): Identification in Diverse Human Tissues and Dendritic Cells , 2001, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[31]  A. Hayman,et al.  Mice lacking tartrate‐resistant acid phosphatase (Acp 5) have disordered macrophage inflammatory responses and reduced clearance of the pathogen, Staphylococcus aureus , 2001, Immunology.

[32]  D. Hume,et al.  Structure, function, and regulation of tartrate-resistant acid phosphatase. , 2000, Bone.

[33]  H. Suominen,et al.  Tartrate‐Resistant Acid Phosphatase 5b: A Novel Serum Marker of Bone Resorption , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[34]  M. Glimcher,et al.  Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. , 2000, Science.

[35]  D. Sheppard,et al.  The Integrin α9β1 Binds to a Novel Recognition Sequence (SVVYGLR) in the Thrombin-cleaved Amino-terminal Fragment of Osteopontin* , 1999, The Journal of Biological Chemistry.

[36]  M. Hatano,et al.  Introduction of an osteopontin gene confers the increase in B1 cell population and the production of anti-DNA autoantibodies. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[37]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[38]  M. Nakanishi,et al.  Improved method for measuring tartrate-resistant acid phosphatase activity in serum. , 1998, Clinical chemistry.

[39]  Sheila J. Jones,et al.  Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disrupted endochondral ossification and mild osteopetrosis. , 1996, Development.

[40]  D. Heinegård,et al.  Dephosphorylation of osteopontin and bone sialoprotein by osteoclastic tartrate-resistant acid phosphatase. Modulation of osteoclast adhesion in vitro. , 1994, The Journal of biological chemistry.

[41]  L. Water,et al.  Adhesive properties of osteopontin: regulation by a naturally occurring thrombin-cleavage in close proximity to the GRGDS cell-binding domain. , 1994, Molecular biology of the cell.

[42]  D. Rimoin,et al.  Possible heterogeneity in spondyloenchondrodysplasia: quadriparesis, basal ganglia calcifications, and chondrocyte inclusions. , 1990, American journal of medical genetics.

[43]  T. Chambers,et al.  Purification and characterization of a tartrate-resistant acid phosphatase from human osteoclastomas. , 1989, The Biochemical journal.

[44]  J. Spranger,et al.  Spondyloenchondrodysplasia. , 1989, Journal of medical genetics.

[45]  K. Scharer.  [A case of infantile generalized lupus erythematosus with unusual bone changes]. , 1958, Helvetica paediatrica acta.

[46]  M. Schwartz,et al.  Acid phosphatases; a review. , 1954, American journal of clinical pathology.

[47]  J. Goverman,et al.  Osteopontin-induced survival of T cells , 2007, Nature Immunology.

[48]  S. Youssef,et al.  Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells , 2007, Nature Immunology.

[49]  L. Glimcher,et al.  Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells. , 2006, Nature immunology.

[50]  G. Abecasis,et al.  Merlin—rapid analysis of dense genetic maps using sparse gene flow trees , 2002, Nature Genetics.

[51]  John Gittus,et al.  Inside story , 1991, Nature.

[52]  Robert C. Wolpert,et al.  A Review of the , 1985 .

[53]  C. Legum,et al.  Spondyloenchondrodysplasia. Enchondromatomosis with severe platyspondyly in two brothers. , 1976, Radiology.